1. Development of A Decision Support Tool for Drug Infusion Performance Evaluation
Poster Title:
Risk-based Scoring Method for Overridden IV Infusions
Wan-Ting (Kerina) Su1,2*,
Poching DeLaurentis1,
Mark Lehto2
1 Regenstrief Center for Healthcare Engineering, 2 School of Industrial Engineering, Purdue University
04/21/2016

2. Drug Infusion Performance Evaluation Cycle

3. Analysis Tools Global Measures: Global and Individual Measures:
Key Performance Indicators (CareFusion)
Infusion Pump Safety Score (Carlson et al., Intermountain Healthcare, 2015)
Global and Individual Measures:
IV Medication Harm Index (Sullivan, 2004; Williams, 2006)
CareFusion. (2016). Knowledge Portal for Infusion Technologies v2.10.
Carlson, R., Johnson, B., & Ensign, R. H. (2015). Development of an “infusion pump safety score.” American Journal of Health-System Pharmacy: AJHP: Official Journal of the American Society of Health-System Pharmacists, 72(10), 777–779.
Sullivan, J. (2004). IV Medication Harm Index: Results of a National Consensus Conference. In Infusion safety: addressing harm with high-risk drug administration (pp. 29–31). San Diego, CA.
Williams, C. K., Maddox, R. R., Heape, E., Richards, H. E., Griffiths, D. L., & Crass, R. E. (2006). Application of the IV Medication Harm Index to Assess the Nature of Harm Averted by “Smart” Infusion Safety Systems: Journal of Patient Safety, 2(3), 132–139.

4. Hypothesis I: Compared to the IV Harm Index, the Risk-based Infusion Score is more related to the estimated probability of ADEs
Hypothesis II: The Risk-based Infusion Score and the probability of ADEs are highly correlated